Photo from Unsplash
Originally Posted On: https://www.raremed.com/insights/raremeds-oncology-program-delivering-timely-therapies/
Cancer is a complex, multifaceted, and ever-evolving disease, presenting in countless forms, each requiring a specialized approach to treatment. Yet amidst this diversity, the need for speed and care are constant. Building an oncology patient support program takes a dynamic partner that’s able to deliver a program that’s as unique as the therapy itself, all while providing ironclad fundamentals, to provide accelerated, compassionate, customized care. RareMed stands alone as the leader in this space, providing concierge-level service to oncology patients, providers, and manufacturers when it matters most.
Timely intervention can significantly improve patient outcomes, as can the empathy and care with which that care is delivered. By addressing the diverse and intricate needs of cancer patients, and delivering every interaction with humanity, RareMed’s oncology programs ensure that life-saving treatments reach those in need faster than ever before. RareMed recognizes the myriad of nuances associated with oncology therapies and has developed a mindful, yet streamlined technology-backed approach to care delivery to ensure that patients receive their prescribed treatments with minimal delay and maximal care, making a tangible difference in their lives.
“Working on a program for pediatric oncology patients involves meticulous planning, coordination, and a deep understanding of both pharmacology and the unique needs of children with cancer. The work is detail-oriented and high-stakes, as even small errors can delay our patients in getting on their therapy. Despite the challenges, it’s incredibly meaningful to contribute to a program that directly supports treatment, improves quality of life, and offers hope to young patients and their families.” -Renee Flinn (Program Manager, Oncology)
Customizing our Approach for Each Oncology Practice and Patient
RareMed Patient Support Programs meet every patient and provider on their level. For example, community oncologists may require more support with reimbursement, prior authorizations, and typically opt to leverage a network specialty pharmacy. Patients may also have less support and resources available from these smaller practices, so providing options like a unique needs assessment and tailored support calls can be important.
Larger institutions and centers of excellence typically have larger teams dedicated to reimbursement and patient care, and may feel they do not require as much support from your branded support offerings. While they may choose to leverage in office dispensing, they still may require copay or free drug programs. It is vital to recognize that each institution is unique, thus customizing support and communications for each is important.
Importance of Rapid Access
Cancer, a disease with a myriad of variations, demands urgent and specialized treatment plans. The significance of rapid, reliable, and consistent access to these therapies becomes apparent when considering the impact of timely intervention on patient outcomes. By developing and enacting focused plans to eliminate barriers, fast-track conversations, cut administrative red tape, and facilitate future deliveries, RareMed eliminates delays and addresses a crucial aspect of cancer care that dramatically impacts the overall success of the therapy.
RareMed’s oncology programs are dedicated to overcoming the variety of administrative hurdles that can delay treatment, thus ensuring that patients begin their therapeutic journeys as swiftly and seamlessly as possible. This dedication starts with the initiation of therapy, but continues as long as therapy persists, to ensure that time is always on our patients’ side. This dedication to rapid access is a cornerstone of our programs, underscoring the critical need to act swiftly at every stage in the fight against cancer.
Streamlined Processes
At the heart of RareMed’s oncology program lies its ability to leverage cutting-edge technology, including proprietary RarePath-based systems, and facilitate efficient coordination between healthcare providers, case managers, and pharmacies. This integration minimizes the barriers often encountered in accessing treatments, thereby enabling patients to commence their therapy without unnecessary waiting periods or tedious processes.
Our programs’ integrated systems facilitate smooth communication and logistics across network stakeholders, creating a seamless experience that reduces the time from diagnosis to treatment initiation. By building unique workflows and customized statuses that match the nature of each oncological product and continually refining these processes over time, RareMed ensures that patients benefit from the most effective, efficient care possible, which is crucial in the time-sensitive world of cancer treatment.
Personalized Support
Understanding that each patient’s journey is unique and often fraught with challenges, RareMed offers personalized support to address the individual needs of those battling cancer. Our dedicated patient care teams work closely with patients to navigate unique disease nuances and complex healthcare environments, providing guidance and assistance throughout their treatment journey. This personalized approach not only helps in managing the practical aspects of care but also offers psychosocial support, empowering patients and their families during difficult times. By tailoring support to the unique circumstances of each disease state, therapy, and indeed each individual, RareMed aims to make complex cancer treatment process as supportive and effective as possible.
Delivering Education that Matters
Educating patients about their treatment scenario and their individual circumstances is a key component of RareMed’s approach. Empowering patients with knowledge enables them to make informed judgments and decisions about their care journey. RareMed works with manufacturers to provide customized, highly effective educational resources and support to help patients understand their treatment and its place in their care journeys. This empowerment is crucial in helping patients feel more in control and engaged in their treatment. By fostering a deeper understanding of their condition and the available treatments, RareMed ensures that patients are active participants in their care, which can lead to better adherence to oncology treatment plans and improved outcomes.
Approaching with Empathy
Education and support is important, but its impact becomes catalytically enhanced if it is delivered with respect, empathy, and warmth. Only RareMed has delivered the highest average Net Promoter Score on MMIT patient satisfaction surveys over the past three years, including an unparalleled 100-point net promoter score in Q1 2025. RareMed oncology teams are trained in the nuances of their associated disease state and therapy to ensure that they can be effective contributors to each patient’s support network. And this technical training is complemented with empathy and care training to ensure that every interaction is positively impactful.
Addressing Financial Barriers
Financial constraints often pose significant challenges to accessing necessary cancer treatments, creating additional stress for patients and their families during an already difficult time. RareMed is unwavering in its commitment to helping patients overcome these financial barriers and access much-needed therapies quickly. We collaborate with biopharma manufacturers to offer multifaceted strategies that aim to minimize the economic burden on patients, ensuring that financial limitations do not impede their access to life-saving therapies. Indeed, RareMed’s in-house, cold-chain-capable non-commercial pharmacy is licensed in all 50 states, and is capable of supporting a myriad of free goods programs.
RareMed’s commitment to financial accessibility extends to facilitating enrollment in foundation, patient assistance, quick-start, bridge, dose exchange, emergency dispense, and clinical trial-driven initiatives. These programs are particularly valuable for cancer patients who may not meet traditional eligibility criteria for financial aid but still require substantial support to afford their treatments. By offering these tailored solutions, RareMed empowers cancer patients to receive the care they need while minimizing financial stress. And if patients don’t qualify for free drug programs themselves, RareMed’s manufacturer-driven copay support programs help to offset costs where possible.
At the heart of RareMed’s mission is a steadfast dedication to providing equitable care access for all cancer patients, regardless of their financial situation. This commitment is reflected in our continuous efforts to collaborate with manufacturers to promote broader access to affordable treatment options.
Future Directions
RareMed remains steadfast in continuously enhancing its oncology programs by embracing emerging technologies and innovative treatment methodologies. Our programs are committed to staying at the forefront of cancer care by continuously evaluating and integrating new care delivery and access advancements, including a robust development roadmap for the RarePath patient management platform and portals. This forward-thinking approach ensures that RareMed remains a leader in providing timely, effective, and compassionate cancer care. By anticipating future trends and challenges in oncology, RareMed is well-positioned to continue delivering outstanding care and making a significant impact on the lives of cancer patients globally.
RareMed’s oncology programs are a testament to our dedication to delivering compassionate, efficient, and life-saving care. Perhaps no other disease state commands the necessity for such dedication. As we continue to refine and expand our oncology services, our focus remains on ensuring that every cancer patient receives the timely and effective treatment they deserve. Through a combination of advanced technology, personalized support, and strategic collaborations, RareMed is poised to continue its tradition of making significant impacts in the field of oncology, improving the lives of countless individuals affected by cancer. Our ongoing commitment to innovation and patient-centered care positions RareMed as a leader in supporting biopharma manufacturers’ fight against cancer, providing hope and healing to patients and their families.
ABOUT RAREMED
RareMed Solutions is the nation’s only concierge patient services provider, focused on complex conditions, including oncology. RareMed partners with biopharma to transform the lives of patients afflicted with devastating complex conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all fifty states, as well as custom-developed associated support technologies, from its headquarters in Pittsburgh, Pennsylvania and bases across the country.
The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction across a variety of patient services models. RareMed’s undivided complex disease focus, high caliber associates, fully dedicated teams, and sophisticated proprietary technology enable it to address the unique needs of complex disease patients. RareMed has been recognized as a top workplace in the nation for multiple consecutive years by USA Today and Newsweek, and consistently sets the benchmark for patient experience according to MMIT patient satisfaction surveys. Visit our website at www.RareMed.com.
